Sinovac’s CoronaVac Trials Show Favorable Results

Early clinical trials show that Sinovac’s COVID-19 vaccine candidate safely induces an immune response in healthy volunteers within a month of vaccination.

Singapore’s HSA Approves Digital Therapeutic For Substance Use Disorder

reSET is a 12-week prescription treatment for substance use disorder.

Singapore Grants ‘Conditional’ Approval For Remdesivir

Singapore's Health Sciences Authority has granted conditional approval of remdesivir as a treatment for patients with severe COVID-19.

Sinovac’s CoronaVac Shows Positive Early Results

Sinovac’s vaccine candidate for COVID-19 showed favorable immunogenicity and safety profiles in Phase I/II clinical trials.

Biolidics To Launch Rapid Test Kit For COVID-19

According to the Singapore-based medtech company, the kit can be used to detect COVID-19 from serum, plasma or blood samples with an accuracy of more than 95 percent in 10 minutes.

Lucence Develops COVID-19 Sample Stabilization Kits

Lucence has developed a kit that can stabilize COVID-19 test samples and is making 10,000 of the kits freely available to the scientific community.

WuXi STA Opens Nucleic Acid Drug Manufacturing Facility

Nucleic acid drugs have the potential to treat neuromuscular and metabolic diseases where small molecule drugs have failed.

Boehringer Ingelheim And Enleofen Bio Strike Billion-Dollar Deal

Enleofen Bio will receive more than US$1 billion in earnout payments from Boehringer Ingelheim’s acquisition of worldwide exclusive rights to its preclinical interleukin-11 platform.

Astrazeneca Launches Three R&D Initiatives In China

With the creation of two new research centres and a billion-dollar fund in China, AstraZeneca looks set to make waves in biomedical research and healthcare in Asia.

WuXi AppTec And BioSolveIT Set Up Molecule Library

The GalaXi® platform grants researchers access to billions of virtual molecules, paving the way for faster drug discovery and development.